-
-
Anti-TNFRSF18 / GITR / CD357 Reference Antibody (ragifilimab),, 50 микрограмм
-
Anti-TNFRSF21 / DR6 / CD358 Reference Antibody (Abbvie patent anti-TNFRSF21),, 50 микрограмм
-
Anti-TNFRSF18 / GITR / CD357 Reference Antibody (Korea Natl.Cancer Ctr. patent anti-GITR),, 50 микрограмм
-
Anti-TNFRSF13C / BAFFR / CD268 Reference Antibody (ianalumab),, 50 микрограмм
-
Anti-TNFRSF17 / BCMA / CD269 Reference Antibody (belantamab),, 50 микрограмм
-
Anti-TNFRSF12A / TWEAKR / CD266 Reference Antibody (enavatuzumab),, 50 микрограмм
-
Anti-TNFRSF10B / TRAILR2 / CD262 Reference Antibody (tigatuzumab),, 50 микрограмм
-
Anti-TNFRSF10B / TRAILR2 / CD262 Reference Antibody (tilogotamab),, 50 микрограмм
-
Anti-TNFRSF10B / TRAILR2 / CD262 Reference Antibody (lexatumumab),, 50 микрограмм
-
Anti-TNFRSF10B / TRAILR2 / CD262 Reference Antibody (drozitumab),, 50 микрограмм
-
Anti-TNFRSF10B / TRAILR2 / CD262 Reference Antibody (benufutamab),, 50 микрограмм
стр.: